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The widespread use of highly active antiretroviral ther-
apy (HAART) over the past years has dramatically 
increased the life expectancy and the quality of life of 
patients infected with HIV-1 (Yeni et al., 2002). 
Improvement in life expectancy has modified the family 
planning of serodiscordant couples and currently some 
couples in which the man is HIV-1-seropositive request 
assisted reproductive technology (ART), while other 
couples opt for free sexual intercourses and the use of 
pre-exposure prophylaxis (PreP) for the negative part-
ner (Vernazza, Graf, Sonnenberg-Schwan, Geit, & 
Meurer, 2011). In both cases, since the semen quality is 
a key factor for reproductive success (Hunault et al., 
2004; Van der Steeg et al., 2007), the possible effect of 
HAART on sperm DNA integrity is of main interest. 
Semen quality of HIV-1-infected men has been evalu-
ated in many studies reporting conflicting results, 
mainly due to the difficulty to analyze such an 
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Abstract
HIV-1-affected couples’ desire to have children and free sexual intercourses with the use of pre-exposure prophylaxis 
for the negative partner has emerged as an alternative option to assisted reproduction in aviremic patients under highly 
active antiretroviral therapy (HAART). It is already known that sperm quality may be impaired in HIV-infected men. The 
underlying physiopathological mechanism is still debated. The aim of this study was to evaluate the effects of HAART 
on sperm DNA fragmentation, comparing HIV-1-infected patients taking HAART versus naïve HIV-1-infected patients. 
This is a prospective case-control study. Sperm nuclear DNA fragmentation rate was evaluated by the sperm chromatin 
dispersion test in 77 HIV-infected men: 53 HIV-1 patients receiving HAART (Group 1) versus 24 naïve HIV-1 patients 
not receiving HAART (Group 2). Complete semen analysis was performed according to WHO 2010 recommendations. 
Patients with HBV infection or HCV infection coinfections and genital tract infections wre excluded. All the patients 
did not present any clinical signs of their disease. Seminal parameters were examined in the two groups, showing no 
significant differences. Increased sperm DNA fragmentation > 30% was demonstrated in 67.9% of patients in Group 
1 and 37.5% of patients in Group 2, respectively (p = .02). A positive but nonsignificant trend toward increased 
fragmentation was reported with advancing patients’ age. In conclusion, sperm nuclear fragmentation rate is increased 
in HIV-1-infected patients taking HAART compared to HIV-1 patients not receiving HAART.
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HIV/AIDS, physiological and endocrine disorders, male infertility, physiological and endocrine disorders, male family 
planning, sexuality, sexually transmitted diseases/infections, physiological and endocrine disorders
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heterogenic group of patients (Bujan et al., 2007; 
Crittenden, Handelsmann, & Stewart, 1992; Dondero 
et al., 1996; Dulioust et al., 2002; Garrido, Meseguer, 
Remohì, Simon, & Pellicer, 2005; Kehl et al., 2011; 
Muller, Coombs, & Krieger, 1998; Nicopoullos, 
Almeida, Ramsay, & Gilling-Smith, 2004). Sperm DNA 
fragmentation (SDF), defined as either single or double-
strand breaks, is one of the major cause of male infertil-
ity. It has been linked to impaired fertilization, poor 
embryo quality, increased spontaneous abortion rates, 
and reduced pregnancy rates after assisted reproduction 
(Evenson, 2011; Henkel et al., 2003; Robinson et al., 
2012; Seli, Gardner, Schoolcraft, Moffatt, & Sakkas, 
2004). DNA fragmentation can be caused by a variety of 
factors such as infection, chemotherapy, radiotherapy, 
smoking, drug use, or advanced age (Fraga, Motchnik, 
Wyrobek, Rempel, & Ames, 1996; Sergerie, Mieusset, 
Croute, Daudin, & Bujan, 2007). One of the major con-
tributors of DNA fragmentation is the increased level of 
reactive oxygen species and oxidative stress that can 
reduce sperm quality in HIV-1-infected men. Increasing 
evidence has identified an association between adverse 
effects of HAART and mitochondrial toxicity, including 
cellular respiratory dysfunction (Moyle, 2004; Pavili 
et al., 2010), decreased mitochondrial energy generation 
(Brinkman, ter Hofstede, Burger, Smeitink, & 
Koopmans, 1998), and changes in spermatozoa metabo-
lism (Kehl et al., 2011). La Sala et al. (2007) reported an 
increase of mitochondrial DNA (mtDNA) content in 
spermatozoa obtained by the swim-up method in 19 
HIV-1 patients all under HAART, while White, Mital, 
Taylor, and St John (2001) reported that sperm mtDNA 
deletions are a consequence of long-term HAART, ana-
lyzing six HIV patients under HAART versus four 
patients never treated. The underlying physiopathologi-
cal mechanism linking poor semen quality and HAART 
is still debated. A longitudinal case control study was 
designed, in order to analyze the effects of HAART reg-
imens on SDF, which could represent a very sensitive 
indicator of HAART toxicity. The aim of this study is 
the evaluation of the effects of HAART in HIV-1-
infected patients in HAART therapy versus naïve HIV-
1-infected patients, being able to exclude the influence 
previous therapies.
Materials and Methods
The study was designed as a prospective case control 
study including semen samples from two groups of 
men attending the Assisted Reproduction Unit in 
“Sacco Hospital” (University of Milan, Italy) asking 
reproductive assistance with their HIV negative part-
ner. The couples were asking reproductive assistance 
as a strategy to reduce the risk of horizontal HIV 
transmission to their seronegative partner. None of 
them had previously attempted spontaneous concep-
tion. All patients were recruited between January 2014 
and June 2016 and provided written informed consent 
prior to enrolment in the study. The Ethics Committee 
of the mentioned institution waived the need for ethics 
approval for the collection, analysis, and publication 
of the obtained and anonymized data for this non-inter-
ventional study.
Patients
Group 1: 53 HIV-1-infected patients taking antiretroviral 
therapy (HAART). Group 2: 24 HIV-1-infected patients, 
who did not receive antiretroviral therapy (naïve con-
trols). These patients were promptly referred from infec-
tious disease specialists before the initiation of the therapy 
in order to receive adequate reproductive counseling and 
assistance to reduce the chance of horizontal transmission 
to the partner.
All the patients did not present any clinical signs of their 
disease. Patients with HBV infection or HCV infection 
coinfections were excluded. All available markers of 
HIV-1 disease like CDC stage, current CD4 + T lympho-
cytes count by flow cytometry, maximum and current 
HIV-1 RNA in blood by RT-PCR, duration of HAART, 
type of antiretroviral drugs were recorded. Patients 
received an extensive andrological work-up, including 
exclusion of varicocele by Doppler ultrasound assessment. 
Mycoplasma Genitalium, Chlamydia trachomatis, and 
Neisseria Gonorrhoeae infections were excluded by ure-
thral swabs. For both groups, smoking and alcohol abuse 
was stopped at least 2 years before the inclusion in the 
study and body mass index was ⩽ 25 kg/m2. Only patients 
with a number of spermatozoa > 5.000.000/ml were 
included in the study.
Semen Analysis
Semen samples were obtained by masturbation after 3 to 
7 days of sexual abstinence. All samples were analyzed 
by the same biologist and at the same laboratory. Samples 
were processed at the laboratory within 2 hr of ejacula-
tion and parameters were assessed as outlined by the 
World Health Organization 2010 criteria (WHO, 2010). 
Semen sperm was bacteria-free in all patients, and the 
leukocyte count was under the WHO threshold (< 1 mil-
lion/ml).
Nuclear Sperm DNA Fragmentation Analysis
Sperm nuclear DNA fragmentation rate was evaluated 
by the sperm chromatin dispersion (SCD) test, the 
Halosperm kit (INDAS laboratories, Madrid, Spain; 
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Fernandez et al., 2003). In brief, an aliquot of a semen 
sample was diluted between 5 million/ml to 10 million/
ml in phosphate-buffered saline (PBS) when needed. 
Eppendorf tubes, provided in the kit, were placed in a 
water bath at 90°–100°C; 60 ml of the diluted semen 
sample were added to the Eppendorf tube and mixed 
with the fused agarose. Of the semen-agarose mix, 20 
microL were pipetted onto slides precoated with aga-
rose and covered with a 22 by 22 mm coverslip. The 
slides were placed on a cold plate in the refrigerator 
(4° C) for 5 min to allow the agarose to produce a 
microgel with the sperm cells embedded within. After 
removing coverslips, the slides were immediately 
immersed horizontally in an acid solution, obtained by 
mixing 80 microL of HCL with 10 ml of distilled water 
and incubated for 7 min. The slides were horizontally 
immersed in 10 ml of the lysing solution for 25 min. 
After washing 5 min in a tray with abundant distilled 
water, the slides were dehydrated in increasing con-
centrations of ethanol (70%, 90%, 100%) for 2 min 
each and then air-dried. Slides may be stained for 
bright-field microscopy. For bright-filed microscopy 
in the improved SCD test (Halosperm kit), slides were 
horizontally covered with a mix of Wright’s staining 
solution (Merck, Darmstadt, Germany) and PBS 
(Merck; 1:1) for 15 min with continuous airflow. Slides 
were briefly washed in tap water and allowed to dry. 
Strong staining is preferred to easily visualize the 
periphery of the dispersed DNA loop halos. For this 
study, 500 spermatozoa per sample were scored under 
the X100 objective of the microscope. The samples 
from patients with SDF values above 30% were con-
sidered abnormal.
Statistical Analysis
All analyses were performed using IBM SPSS version 
21.0 (Armonk, NY: IBM Corp) and R version 3.2.1 
(The R Foundation for Statistical Computing). P values 
⩽ .05 were considered significant. Appropriate descrip-
tive statistics were calculated: median, minimum and 
maximum, quartiles for quantitative variables, and 
absolute frequencies and percentages for categorical 
variables. Population characteristics were compared 
using χ2 or exact tests for ordinal variables and Mann-
Whitney U test for continuous variables. Mann–
Whitney U test was used to compare medians of semen 
fragmentation rate, sperm motility, and sperm cells 
after capacitation between the two groups.
Comparison data are presented as odds ratio (OR; 
Mantel–Haenszel), p value and confidence interval (CI) 
and ORs refer to the effect of therapy on fragmentation, 
adjusted for the age of the patients.
Results
The baseline characteristics of HIV-1-infected patients of 
the two groups are reported in Table 1. At the time of 
semen collection in group 1, 16/53 men (30%) were receiv-
ing two or more Nucloside Reverse transcriptase inhibitor 
(NRTI), 18/53 (34%) men NRTI in combination with pro-
tease inhibitors therapy, and 19/53 men (36%) were under 
two NRTI in combination with efavirenz. The median 
therapy duration was 8 (1–14) years and therapy was only 
HAART. The median disease duration was 14 (3–32) 
years. Viral load was undetectable in 100% of patients and 
plasma CD4 + T lymphocyte count measured by flow 
Table 1. Population Characteristics.
Group 1 - HAART
(n = 53)
Group 2 - NAÏVE
(n = 24) p value
Age (years); median (range) 42 (28–54) 39 (25–49) NS
Duration of HIV-1 infection (years); median (range) 14 (3–32) 5 (1–27) NS
Time under HAART (years); median (range) 8 (1–14) –  
CD4 count (cells/ml); median (range) 470 (71–1670) 445 (149–1086) NS
Undetectable viral load, n (%) 53 (100%) 24 (100%)  
Educational level
High school, n (%) 24 (45.3) 12 (50) NS
University, n (%) 5 (9.4) 3 (12.5) NS
Unknown, n (%) 24 (45.3) 9 (37.5) NS
Employed, n (%) 48 (90.6) 21 (87.5) NS
Route of HIV-1 transmission
Injection drugs, n (%) 2 (4%) 1 (4%) NS
Sexual transmission, n (%) 31 (58%) 21 (88%) NS
Blood product transmission, n (%) 20 (38%) 2 (8%) NS
Note. The comparison between groups was performed using χ2 or exact tests for categorical variables and Mann–Whitney U test for continuous 
variables. Statistically significant difference as p < .05. HAART = highly-active antiretroviral therapy; NS = not significant.
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cytometry was above 200/mm3 in both groups. In Group 2, 
the median disease duration was 5 (1–27) years. In the 
majority of cases, sexual transmission represented the 
main route of infection among men, accounting for 31/53 
(58%) in Group 1 and 21/24 (88%) in Group 2. 20/53 
(38%) patients in Group 1 and 2/24 (8%) in Group 2 were 
infected hematologically, while 2/53 (4%) and 1/24 (4%) 
were injection drug users, respectively. The median age in 
Group 1 was 42 (28–54) years, whereas in Group 2 was 39 
(25–49) years. The influence of men’s age difference 
between the two groups was considered in the statistical 
analysis of sperm DNA fragmentation.
Seminal parameters (sperm volume, total sperm count, 
progressive motility, and morphology) were examined in 
the two groups of patients and are reported in Table 2. No 
significant differences were found in any of the parame-
ters assessed between samples of patients receiving 
HAART and samples of patients not taking antiretroviral 
therapy.
Sperm Nuclear Fragmentation Evaluation
In Table 3, the analysis of the data indicates that the 
median of sperm nuclear fragmentation rate, expressed 
as DNA Fragmentation Index (DFI %), was significantly 
increased in HIV-1-infected patients taking antiretroviral 
therapy (Group 1) compared with the group of HIV-1-
infected patients, who did not receive antiretroviral ther-
apy (Group 2). In Group 1, 36/53 (67.9%) patients had 
SDF > 30%, with a median rate of fragmentation of 
39%, whereas in Group 2, 9/24 (37.5%) patients had 
SDF > 30%, with a median rate of fragmentation of 
22.5% (p = .0001; Table 3). The semen motility a + b 
and the sperm cells after capacitation expressed in 
Million/0, 5 were not significantly different. Figure 1 
summarizes the main findings of seminal parameters and 
SDF in Group 1 versus Group 2.
In addition, in order to exclude the effect of the age of 
the patients on these results, DNA fragmentation was 
analyzed according to three different age groups, identi-
fying a positive correlation between increasing age and 
DNA fragmentation rate in each group. Nevertheless, this 
correlation is not statistically significant. Table 4 indi-
cates the number and percentages of patients, age-strati-
fied, with SDF (DFI) > 30%.
No correlation was found between increased DNA 
fragmentation and any classes of antiretroviral drugs in 
patients receiving therapy (Figure 2).
Discussion
The present study demonstrates elevated SDF in HIV-1-
infected patients taking antiretroviral therapy compared 
to patients completely antiretroviral therapy naïve, 
excluding the bias of the effects of previous therapy. 
Furthermore, analyzing the three most common therapeu-
tic regimes in the treatment of HIV infection disease, no 
differences in SDF rate were identified. To our knowl-
edge, only Frainais et al. (2010) in their study examined 
the sperm DNA integrity comparing HIV-1-infected 
patients in therapy versus healthy uninfected patients, 
reporting an increased DNA fragmentation in HIV-1-
infected men taking HAART. Frainais et al. (2010) 
hypothesized both a direct and indirect effect of the virus 
Table 2. Different Seminal Parameters in Group 1 (HAART) Versus Group 2 (NAÏVE).
Group 1 - HAART
(n = 53)
Group 2 - NAÏVE
(n = 24) p value OR (95% CI)
Patients with ejaculate volume <1.5 ml, n (%) 7 (13.2) 1 (4.2) .21 3.7 [0.42, 31.6]
Patients with concentration of spermatozoa 
 < 39 × 106 /ejaculate, n (%)
25 (47.2) 16 (66.7) .11 0.4 [0.16, 1.2]
Patients with progressive motility < 40%, n (%) 20 (37.7) 10 (41.7) .71 0.8 [0.31, 2.2]
Patients with abnormal morphology < 4%, n (%) 4 (7.5) 5 (20.8) .09 0.3 [0.07, 1.3]
Note. The comparison between groups was performed using χ2 test.
Table 3. Semen Fragmentation, Motility, and Sperm Cells after Capacitation in Group 1 (HAART) Versus Group 2 (NAÏVE).
Group 1 - HAART
(n = 53)
Group 2 - NAÏVE
(n = 24) p value
Fragmentation (DFI %); Median (range) 39 (13–78) 22.5 (8–66) .0001
Motility a + b (%); Median (range) 43 (10–73) 45 (13–58) .67
Sperm cells after capacitation, (Million /0,5); Median (range) 4 (0.1–20) 3 (0.025–14) .64
Note. The comparison between groups was performed using Mann–Whitney U test.
DFI = DNA fragmentation index (%).
1828 American Journal of Men’s Health 12(6)
on DNA sperm integrity and the possibility of antiretrovi-
ral drug-mediated damage. The authors used healthy sub-
jects as a control group and this could represent a bias in 
the interpretations of the results.
Several studies have reported semen alterations in 
HIV-infected men, such as decreased motility, sperm con-
centration, total sperm count, or volume ejaculate 
(Crittenden et al., 1992; Dondero et al., 1996; Dulioust 
et al., 2002; Kehl et al., 2011; Muller et al., 1998; 
Nicopoullos et al., 2004). Other reports did not identify, 
however, any difference (Bujan et al., 2007; Garrido 
et al., 2005). Since it is difficult to separate the role of 
HIV-1 infection from the adverse effects of therapy, the 
debate on this issue is still open.
There are several possible explanations for the observed 
sperm changes in patients receiving HAART. Therapeutic 
control of HIV-1 replication by antiretroviral medications 
is associated with increased oxidant stress in many patients 
and oxidant stress is not increased in patients with uncon-
trolled viral replication (Hulgan et al., 2003). Transport 
for drugs through the endothelial barrier can occur for pas-
sive diffusion, which is the primary driving force for drug 
transport to the lumen of the male genital tract, or for 
active cellular mechanism. Lowe et al. (2004), in contrast 
with previous suggestions (Bart et al., 2002; Holash, 
Harik, Perry, & Stewart, 1993), argue that the testicular 
extraluminal tissue is not a drug-deprived area and most 
antiretroviral drugs show good penetration in the male 
genital tract, potentially affecting spermatogenesis.
A second possible mechanism determining reduced 
sperm quality in HIV-1-infected men taking HAART, could 
be the changes in spermatozoa metabolism (Kehl et al., 
2011) due to mitochondrial toxicity (Brinkman et al., 1998; 
Lewis & Dalakas, 1995). Maternally inherited, mitochon-
dria are unique in that they contain their own circular double 
stranded genome, spanning 16.6 kb in length and encoding 
13 subunits of the respiratory chain complexes, essential for 
the production of ATP in the cell (May-Panloup et al., 2003; 
Reynier et al., 2001). Disruption of mitochondrial electron 
transport flow in human spermatozoa results in generation 
of Reactive oxygen species (ROS) (Koppers, De Iuliis, 
Finnie, McLaughlin, & Aitken, 2008) and overproduction of 
ROS causes lipid peroxidation, responsible for sperm 
Figure 1. Differences in semen parameters in Group receiving HAART therapy versus naive Group. Fragmentation index 
(DFI%) is significantly highest in HAART group compared to naive one.
Table 4. Comparison of Sperm DNA Fragmentation in Group 
1 (HAART) Versus Group 2 (NAÏVE) According to Age.
Sperm DNA 
Fragmentation > 30%
Group 1- HAART
(n = 53)
Group 2 - NAÏVE
(n = 24)
Age 25−38 years
(n = 28)
10/15 (66.7%)
n = 15
5/13 (38.5%)
n = 13
Age 39−43 years
(n = 24)
11/17 (64.7%)
n = 17
3/7 (42.9%)
n = 7
Age 44−54 years
(n = 25)
15/21 (71.4%)
n = 21
1/4 (25%)
n = 4
Total HIV-1-
infected patients
36/53 (67.9%)
n = 53
9/24 (37.5%)*
n = 24
Note. OR (Mantel–Haenszel): 3.51, p = .02, 95% CI [1.22, 10.12].
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chromatin damage and DNA strand breaks (Aitken & 
Koppers, 2011; Blumer et al., 2012). A combination of anti-
retroviral therapy, duration of the therapy, duration of the 
infection and immunological status are all important param-
eters that should be taken into account when evaluating the 
semen quality (Bujan et al., 2007; Kehl et al., 2011; 
Nicopoullos, Almeida, Vourliotis, & Gilling-Smith, 2011; 
Pilatz et al., 2014; Robbins et al., 2001; Van Leeuwen et al., 
2008). In addition, in order to exclude that the age of the 
patients could have influenced these results, DNA fragmen-
tation was analyzed in relation to the men’s age. Although 
there is no clear consensus regarding the implication of male 
age on semen parameters, multiple studies have demon-
strated that sperm DNA damage increases with advancing 
male age (Moskovtsev, Willis, White, & Mullen, 2007; 
Wyrobek et al., 2006). The results of the present study show 
a correlation between patients’ age and increased fragmenta-
tion, but the difference is not statistically significant. 
Previously published studies reported different findings 
regarding the impact of male age on semen quality. Kidd, 
Eskenazi, and Wyrobek (2001) reported a decline in semen 
volume, sperm motility, and morphology, while other stud-
ies identified a linear decline in semen volume (Dain, 
Auslander, & Dirnfeld, 2011). Sperm nuclear DNA frag-
mentation rate was evaluated by the SCD test. Several tests 
are available to analyze sperm nuclear DNA fragmentation, 
but no consensus has been reached yet with regard to which 
tests are the most predictive of infertility, due to the fact that 
all currently available techniques vary in their diagnostic 
accuracy and clinical value (Ribeiro et al., 2017). Ribas-
Maynou et al. (2013) have reported a comprehensive analy-
sis of SDF different assays and they demonstrate that the 
cut-off, sensitivity, and specificity results obtained by the 
SCD do not differ from previously published works 
(Fernandez et al., 2005; Nunez-Calonge et al., 2012; Velez 
de la Calle et al., 2008), showing a good capacity of this 
technique to assess male infertility. Feijó and Esteves (2014) 
conclude that the SCD test is more sensitive than the TUNEL 
assay for the assessment of DNA damage in men with unex-
plained infertility. In the study by Ribas-Maynou et al. 
(2013) the cut-off for SCD test is 22.75%, the sensitivity is 
0.73, and specificity is 0.91. It can be concluded that the 
alkaline Comet assay, the SCD test, SCSA (Sperm Chromatin 
Structure Assay), and the TUNEL assay are useful to distin-
guish fertile and infertile patients, with a nonsignificant dif-
ference, except for the alkaline Comet assay being the best 
predictor of male infertility.
Limitations
The limitations of this study must be acknowledged, prin-
cipally linked to small size of patients included, and cau-
tion is warranted when interpreting results. In addition, 
the design of the study did not allow the assessment of 
SDF for the same patient before and after the initiation of 
antiretroviral therapy.
Conclusion
The results of this study demonstrate that sperm nuclear 
fragmentation rate is increased in HIV-1-infected patients 
taking antiretroviral therapy when compared to naïve 
HIV-1-infected patients. Furthermore, no correlations 
between antiretroviral therapy and semen parameters like 
total sperm count, progressive motility, or morphology 
has been observed. Further research is needed to define 
the mechanisms of the potential effect of HAART on 
sperm and sperm mitochondrial DNA.
Figure 2. Differences in semen fragmentation index in three therapeutic regimens.
NRTI: Nucloside Reverse transcriptase inhibitor; NRTI + efavirenz; NRTI + IP (Protease inhibitor).
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